These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35477493)

  • 1. European Network for Health Technology Assessment's Response to COVID-19: Rapid Collaborative Reviews on Diagnostic Tests and Rolling and Rapid Collaborative Reviews on Therapeutics.
    Ballini L; Wild C; Djuric O; Mayer-Ferbas J; Willemsen A; Huic M;
    Int J Technol Assess Health Care; 2022 Mar; 38(1):e22. PubMed ID: 35477493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing a quality management system for the European Network for Health Technology Assessment (EUnetHTA): toward European HTA collaboration.
    Luhnen M; Ormstad SS; Willemsen A; Schreuder-Morel C; Helmink C; Ettinger S; Erdos J; Fathollah-Nejad R; Rehrmann M; Hviding K; Rüther A; Chalon PX
    Int J Technol Assess Health Care; 2021 Apr; 37(1):e59. PubMed ID: 33902782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European network for Health Technology Assessment Joint Action (EUnetHTA JA): a process evaluation performed by questionnaires and documentary analysis.
    Woodford Guegan E; Cook A
    Health Technol Assess; 2014 Jun; 18(37):1-296. PubMed ID: 24913263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of Relative effectiveness assessments (REAs) of pharmaceuticals at the European network for health technology assessment (EUnetHTA): A first step towards a consolidated European perspective on comparative effectiveness & safety?
    Chassagnol F; Marcelli G; Wagle J; Giuliani G; Traub D; Schaub V; Ruof J
    Health Policy; 2020 Sep; 124(9):943-951. PubMed ID: 32622542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HTA goes Europe: European collaboration on joint assessment and methodological issues becomes reality].
    Nachtnebel A; Mayer J; Erdös J; Lampe K; Kleijnen S; Schnell-Inderst P; Wild C
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):291-9. PubMed ID: 26354129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Information specialist collaboration in Europe: collaborative methods, processes, and infrastructure through EUnetHTA.
    Waffenschmidt S; van Amsterdam-Lunze M; Gomez RI; Rehrmann M; Harboe I; Hausner E
    Int J Technol Assess Health Care; 2020 Oct; 37():e20. PubMed ID: 33081862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the planned and ongoing project (POP) database a suitable tool to reduce duplication in the process of assessing new health technologies in the European Union? Preliminary experience in the context of the EUnetHTA Joint Action Project Framework (2010-2012).
    Vondeling H; Sandvei M
    Int J Technol Assess Health Care; 2014 Nov; 30(5):504-7. PubMed ID: 25747559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical tools and methods for health technology assessment in Europe: structures, methodologies, and tools developed by the European Network for Health Technology Assessment, EUnetHTA.
    Kristensen FB; Lampe K; Chase DL; Lee-Robin SH; Wild C; Moharra M; Garrido MV; Nielsen CP; Røttingen JA; Neikter SA; Bistrup ML;
    Int J Technol Assess Health Care; 2009 Dec; 25 Suppl 2():1-8. PubMed ID: 20030885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European network for health technology assessment, EUnetHTA: planning, development, and implementation of a sustainable European network for health technology assessment.
    Kristensen FB; Mäkelä M; Neikter SA; Rehnqvist N; Håheim LL; Mørland B; Milne R; Nielsen CP; Busse R; Lee-Robin SH; Wild C; Espallargues M; Chamova J;
    Int J Technol Assess Health Care; 2009 Dec; 25 Suppl 2():107-16. PubMed ID: 20030898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Building a model of health technology assessment cooperation: lessons learned from EUnetHTA joint action 3.
    Garrett Z; Imaz-Iglesia I; Willemsen A
    Int J Technol Assess Health Care; 2022 Jan; 38(1):e14. PubMed ID: 35086599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involving stakeholders and developing a policy for stakeholder involvement in the European network for health technology assessment, EUnetHTA.
    Nielsen CP; Lauritsen SW; Kristensen FB; Bistrup ML; Cecchetti A; Turk E;
    Int J Technol Assess Health Care; 2009 Dec; 25 Suppl 2():84-91. PubMed ID: 20030895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Methodological guideline for the efficacy and safety assessment of new pharmaceuticals: implementation of EUnetHTA's recommendations].
    Ubago Pérez R; Castillo Muñoz MA; Banqueri MG; García Estepa R; Alfaro Lara ER; Vega Coca MD; Beltrán Calvo C; Molina López T
    Gac Sanit; 2017; 31(4):336-341. PubMed ID: 28062129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries.
    ; Heintz E; Gerber-Grote A; Ghabri S; Hamers FF; Rupel VP; Slabe-Erker R; Davidson T
    Pharmacoeconomics; 2016 Jan; 34(1):59-76. PubMed ID: 26446858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EUnetHTA relative effectiveness assessments: efforts to increase usability, transparency and inclusiveness.
    Willemsen A; Ettinger S; Helmink C; Erdos J; Hviding K; Ormstad SS
    Int J Technol Assess Health Care; 2022 May; 38(1):e41. PubMed ID: 35615861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stakeholder perspectives on cooperation in the clinical and nonclinical health technology assessment domains.
    Zimmermann G; Michelmore S; Hiligsmann M
    Int J Technol Assess Health Care; 2023 May; 39(1):e29. PubMed ID: 37212049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European Collaboration in Health Technology Assessment (HTA): goals, methods and outcomes with specific focus on medical devices.
    Erdös J; Ettinger S; Mayer-Ferbas J; de Villiers C; Wild C
    Wien Med Wochenschr; 2019 Sep; 169(11-12):284-292. PubMed ID: 30725440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collaborative models for the joint production of core health technology assessments: negative and positive aspects for the joint work of different European agencies.
    Lo Scalzo A; Vicari N; Corio M; Perrini MR; Jefferson T; Gillespie F; Cerbo M
    Int J Technol Assess Health Care; 2014 Nov; 30(5):536-43. PubMed ID: 25747564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Description of the use of multicriteria to support pricing and reimbursement decisions by European health technology assessment bodies.
    Elvira D; Obach M; Pontes C
    BMC Health Serv Res; 2021 Aug; 21(1):814. PubMed ID: 34391431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.